VMAT2 and VMAT1 are reliable markers for differentiation of gastric endocrine hyperplasia and neoplasia from ECL and EC and potentially valuable markers in categorizing neuroendocrine cancer [113,114]. This evidence concerns the gene SLC18A1 and neoplasm.